Switching patients to aripiprazole from other antipsychotic agents: a multicenter randomized study

被引：0
作者：
Daniel E. Casey
William H. Carson
Anutosh R. Saha
Amy Liebeskind
Mirza W. Ali
Darlene Jody
Gary G. Ingenito
机构：
[1] VA Medical Center,Mental Health Division (P3MIRECC)
[2] Otsuka America Pharmaceutical Inc,undefined
[3] Otsuka Maryland Research Institute,undefined
[4] Lenox Hill Hospital,undefined
[5] Bristol-Myers Squibb,undefined
来源：
Psychopharmacology | 2003年 / 166卷
关键词：
Aripiprazole; Schizophrenia; Atypical antipsychotic; Switching;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：391 / 399
页数：8
相关论文
共 50 条
  • [21] A non-randomized study to investigate the effects of the atypical antipsychotic aripiprazole on the steady-state pharmacokinetics of lamotrigine in patients with bipolar I disorder
    Schieber, Frank C.
    Boulton, David W.
    Balch, Alfred H.
    Croop, Robert
    Mallikaarjun, Suresh
    Benson, Jeannine
    Carlson, Berit X.
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2009, 24 (02) : 145 - 152
  • [22] Response prediction in treatment of patients with schizophrenia after switching from oral aripiprazole to aripiprazole once-monthly
    Schoettle, Daniel
    Wiedemann, Klaus
    Correll, Christoph U.
    Janetzky, Wolfgang
    Friede, Michael
    Jahn, Holger
    Brieden, Andreas
    SCHIZOPHRENIA RESEARCH, 2023, 260 : 183 - 190
  • [23] The cognitive profile of aripiprazole differs from that of other atypical antipsychotics in schizophrenia patients
    Hori, Hikaru
    Yoshimura, Reiji
    Katsuki, Asuka
    Hayashi, Kenji
    Ikenouchi-Sugita, Atsuko
    Umene-Nakano, Wakako
    Nakamura, Jun
    JOURNAL OF PSYCHIATRIC RESEARCH, 2012, 46 (06) : 757 - 761
  • [24] Aripiprazole augmentation versus antidepressant switching for patients with major depressive disorder: A 6-week, randomized, rater-blinded,prospective study
    Han, Changsu
    Wang, Sheng-Min
    Kwak, Kyung-Phil
    Won, Wang-Yeon
    Lee, HwaYoung
    Chang, Chia Ming
    Tang, Tze Chun
    Pae, Chi-Un
    JOURNAL OF PSYCHIATRIC RESEARCH, 2015, 66-67 : 84 - 94
  • [25] Efficacy and Tolerability of Aripiprazole: A 26-Week Switching Study from Oral Antipsychotics
    Lee, Jung-Sun
    Chung, Seockhoon
    Lee, Joon-Noh
    Kwon, Jun Soo
    Kim, Do Hoon
    Kim, Chul Eung
    Oh, Kang Seob
    Jeon, Yang-Whan
    Lee, Min-Soo
    Lim, Myung Ho
    Chang, Hye-Ryein
    Kim, Chang Yoon
    PSYCHIATRY INVESTIGATION, 2010, 7 (03) : 189 - 195
  • [26] Long-term effectiveness of flexibly dosed paliperidone extended-release: comparison among patients with schizophrenia switching from risperidone and other antipsychotic agents
    Kim, Eun Young
    Chang, Sung Man
    Shim, Joo Cheol
    Joo, Eun Jeong
    Kim, Jae Jin
    Kim, Yong Sik
    Ahn, Yong Min
    CURRENT MEDICAL RESEARCH AND OPINION, 2013, 29 (10) : 1231 - 1240
  • [27] Abnormally low prolactin levels in schizophrenia patients after switching to aripiprazole in a randomized trial: a biomarker for rebound in psychotic symptoms?
    Jen, Ya-Wen
    Hwang, Tzung-Jeng
    Chan, Hung-Yu
    Hsieh, Ming H.
    Liu, Chen-Chung
    Liu, Chih-Min
    Hwu, Hai-Gwo
    Kuo, Ching-Hua
    Lin, Yi-Ting
    Chien, Yi-Ling
    Chen, Wei J.
    BMC PSYCHIATRY, 2020, 20 (01)
  • [28] Switching patients with schizophrenia from paliperidone palmitate to aripiprazole lauroxil: A 6-month, prospective, open-label study
    Miller, Brian J.
    Claxton, Amy
    Du, Yangchun
    Weiden, Peter J.
    Potkin, Steven G.
    SCHIZOPHRENIA RESEARCH, 2019, 208 : 44 - 48
  • [29] Abnormally low prolactin levels in schizophrenia patients after switching to aripiprazole in a randomized trial: a biomarker for rebound in psychotic symptoms?
    Ya-Wen Jen
    Tzung-Jeng Hwang
    Hung-Yu Chan
    Ming H. Hsieh
    Chen-Chung Liu
    Chih-Min Liu
    Hai-Gwo Hwu
    Ching-Hua Kuo
    Yi-Ting Lin
    Yi-Ling Chien
    Wei J. Chen
    BMC Psychiatry, 20
  • [30] Switching antipsychotic treatment to aripiprazole in psychotic patients with neuroleptic-induced tardive dyskinesia: a 24-week follow-up study
    Chan, Chia-Hsiang
    Chan, Hung-Yu
    Chen, Yen-Ching
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2018, 33 (03) : 155 - 162
12345